Fig. 3
MiR-1238 attenuates NSCLC cell growth, metastasis, and EMT by targeting ZEB2. A Test of miR-1238 and ZEB2 mRNA in cells after transfection by RT-qPCR; B examination of cell ZEB2 and E-cadherin, N-cadherin, Vimentin by Western blot; C test of cell proliferation after transfection by CCK8 assay; D detection of cell apoptosis rate after transfection by flow cytometry; E, F examination of cell migration and invasion after transfection by Transwell; *P < 0.05, ** P < 0.01. N = 3; the data in the figure were in the form of mean ± SD